Back to search
FDAFDA · Food and drugs·Recall number D-0472-2025

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Published June 25, 2025 · Recall initiated: May 29, 2025

Summary

FDA records drug Class II recall D-0472-2025, published June 25, 2025 and initiated May 29, 2025. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 48,000 vials; Lot: Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

What to do

Voluntary: Firm initiated · Letter

Get an email if GENTAMICIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GENTAMICIN
Manufacturer
Eugia US LLC
Distributor
Nationwide in the USA
Lot
Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25 recalled?

Yes. FDA published recall D-0472-2025 on June 25, 2025. Reported hazard: Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GENTAMICIN.